Cleary Gottlieb is advising pharmaceutical company Allergan on its USD160 billion merger with Pfizer which will create a new major player in the global biopharmaceuticals market.
Under the terms of the proposed transaction, the businesses of Pfizer and Allergan will be combined under Allergan plc, which will be renamed Pfizer plc. The transaction is subject to regulatory approvals and is expected to close in the second half of 2016.
The multidisciplinary Cleary Gottlieb team advising Allergan is led by corporate/M&A partners Paul Shim and Jim Langston. The corporate/M&A team also includes associates Kimberly Spoerri, Kyle Harris, Luke Ricci, Raymond Palmer and Jonathan Brice, and law clerks Derrick Davis and Joshua Lee. Partner Michael Albano, counsel Kathleen Emberger, associates Laura Bagarella and Lisa McKenna, and law clerk Alexander Kurtz are providing employee compensation and benefits advice. Partner Romano Subiotto, associates Niklas Maydell, Asa Hallsdottir, Andreas Piehlmeier, Omar El-Khatib, Sibylle Vieille-Cessay, Burcu Can, Aude-Laure Delbac, Hafiz Shariff, and stagiaire Marta Janek are providing non-US antitrust advice. Partners Jeff Karpf and Meme Peponis, counsel Helena Grannis, and associates Aditi Eleswarapu, Azeemah Kola, and Shirley Lo are providing capital markets, securities and financing advice. Partner Daniel Ilan and associate Brendan Cohen are providing intellectual property advice. Counsel W. Richard Bidstrup and associate Beau Sterling are providing environmental advice. Counsel David Herrington and Avi Luft, and associates Mark Grube and Alexandra Eber are providing litigation advice.
All lawyers are based in New York, apart from Subiotto who is based in Brussels and London, Maydell, Hallsdottir, Piehlmeier, El-Khatib, Vieille-Cessay, Can, Delbac, Shariff, and Janek who are based in Brussels, and Sterling who is based in Washington.
